NIH 2021 R44 AG |
An RSV Prefusion F Vaccine that Overcomes Immunosenescence Yondola, Mark / Calder Biosciences, Inc. |
|
NIH 2020 R44 AG |
An RSV Prefusion F Vaccine that Overcomes Immunosenescence Yondola, Mark / Calder Biosciences, Inc. |
|
NIH 2019 R44 AG |
An RSV Prefusion F Vaccine that Overcomes Immunosenescence Yondola, Mark / Calder Biosciences, Inc. |
|